PT-141 (Bremelanotide)
Personalized prescription therapy
Available by prescription only, following evaluation by a licensed healthcare provider.
Meet PT-141
PT-141 (bremelanotide) is a melanocortin receptor agonist that works within the central nervous system pathways associated with sexual response and desire, rather than acting on blood flow directly. It's typically used on an as-needed basis, ahead of anticipated sexual activity, as part of a provider-guided treatment plan.
How It's Taken
A subcutaneous injection or sublingual troche, taken as directed by your provider ahead of anticipated activity. Your provider personalizes timing and dose based on your history and response.
Available Formats
• Injection: 10mg/mL, supplied in a 5mL vial (50mg total) — provides multiple as-needed doses per vial.
What This May Support
• May support sexual desire and arousal
• Offers an as-needed, non-hormonal approach for both men and women
• Personalized dosing guided by your provider
Who It's For
PT-141 may be appropriate for adults seeking medical support for low sexual desire or arousal concerns as part of a personalized treatment plan. A licensed provider determines whether treatment is appropriate based on your medical history, current health, and goals.
Important Information
• Prescription required; issued only if medically appropriate.
• Compounded PT-141 (bremelanotide) is not reviewed or approved by the FDA in this compounded form, and is not a generic or FDA-approved equivalent of Vyleesi®.
• Compounded medications are custom-prepared for your specific needs.
• Individual results vary.
Links:
Safety Information · FDA Disclosure · How It Works
Related:
Explore other Cellular Wellness treatmentsPT-141 (Bremelanotide)
Personalized prescription therapy
Available by prescription only, following evaluation by a licensed healthcare provider.
Meet PT-141
PT-141 (bremelanotide) is a melanocortin receptor agonist that works within the central nervous system pathways associated with sexual response and desire, rather than acting on blood flow directly. It's typically used on an as-needed basis, ahead of anticipated sexual activity, as part of a provider-guided treatment plan.
How It's Taken
A subcutaneous injection or sublingual troche, taken as directed by your provider ahead of anticipated activity. Your provider personalizes timing and dose based on your history and response.
Available Formats
• Injection: 10mg/mL, supplied in a 5mL vial (50mg total) — provides multiple as-needed doses per vial.
What This May Support
• May support sexual desire and arousal
• Offers an as-needed, non-hormonal approach for both men and women
• Personalized dosing guided by your provider
Who It's For
PT-141 may be appropriate for adults seeking medical support for low sexual desire or arousal concerns as part of a personalized treatment plan. A licensed provider determines whether treatment is appropriate based on your medical history, current health, and goals.
Important Information
• Prescription required; issued only if medically appropriate.
• Compounded PT-141 (bremelanotide) is not reviewed or approved by the FDA in this compounded form, and is not a generic or FDA-approved equivalent of Vyleesi®.
• Compounded medications are custom-prepared for your specific needs.
• Individual results vary.
Links: Safety Information · FDA Disclosure · How It WorksRelated: Explore other Cellular Wellness treatmentsYou May Also Like
